Kit Summary
Antibodies for MSC verification according to the markers proposed by the International Society for Cellular Therapy.
Why use the ISCT-recommended Markers to Verify MSC Identity?
The different methods used to isolate, culture, differentiate, and define mesenchymal stem cells (MSCs) can lead to experimental variability and contradictory data. In an attempt to standardize the definition of mesenchymal stem cells, in 2006, the International Society for Cellular Therapy (ISCT) proposed the minimal criteria to define MSCs.1 See Details
Included in these criteria were recommendations for the positive and negative expression of a specific set of surface antigens. Specifically, the ISCT criteria recommends that 95% or greater of the MSC population must express CD73/5'-Nucleotidase, CD90/Thy1, and CD105/Endoglin as measured by flow cytometry and that 2% or less of the MSC population should express CD34, CD45, CD11b/Integrin alpha M or CD14, CD79 alpha or CD19, and HLA Class II.
R&D Systems Human Mesenchymal Stem Cell Marker Verification Multi-Color Flow Cytometry Kit (Catalog # FMC020) includes all of the antibodies needed to assess MSC marker expression according to the ISCT's definition of human MSCs. To fulfill both the phenotypic and functional definition of human MSCs according to the ISCT criteria, cells can be assessed using both the Human Mesenchymal Stem Cell Marker Verification Multi-Color Flow Cytometry kit and the Human Mesenchymal Stem Cell Functional Identification Kit.
References
- Dominici, M. et al. (2006) Cytotherapy 8:315.
Human Mesenchymal Stem Cell Marker Verification Multi-Color Flow Cytometry Kit:
- Provides antibodies to the MSC markers recommended by the ISCT's minimal criteria to define human MSCs.
- Can be used with the Human MSC Functional ID kit to define MSCs according to the ISCT recommendations.
- Reduces experimental variability by defining the starting cell population.
Mesenchymal Stromal Cells or Mesenchymal Stem Cells?
The term ‘mesenchymal stromal cells’ is commonly used to describe a heterogeneous population of cultured cells that are adherent to plastic, have a distinct morphology, and express a specific set of marker proteins. Within this heterogeneous population are cells referred to as ‘mesenchymal stem cells.’ See Details
Mesenchymal stem cells are multipotent, self-renewing cells that have the ability to differentiate into adipocytes, chondrocytes, and osteoblasts when cultured in vitro.
2006 Proposed Change to MSC Nomenclature
Although mesenchymal stromal cells were once referred to as ‘mesenchymal stem cells,' a change to ‘mesenchymal stromal cells' was proposed by the International Society for Cellular Therapy in 2006.1
The change in nomenclature originates from two important factors:
- Methods used to isolate mesenchymal stem cells yield a heterogeneous population of cells with only a fraction of these cells demonstrating multipotency.
- The absence of direct evidence that mesenchymal stem cells can self-renew and differentiate in vivo.
Use of Mesenchymal Stem and Stromal Cell Terminology
Data supporting MSC self-renewal and multipotency have been obtained using in vitro conditions, which does not adequately reflect the in vivo environment. The lack of in vivo data has led some researchers to question the validity of the term ‘mesenchymal stem cell' providing further support for the use of ‘mesenchymal stromal cells' to describe MSCs.2 While ‘mesenchymal stromal cells' may be the more scientifically accurate term for MSCs, the two terms are often used interchangeably in the literature. R&D Systems recognizes the use of both mesenchymal stem cells and mesenchymal stromal cells and uses ‘MSC' to indicate mesenchymal stem/stromal cells to account for both designations.
Definitions of Mesenchymal Stromal Cells and Mesenchymal Stem Cells
- Mesenchymal Stromal Cells – A heterogeneous population of cultured cells with similar characteristics such as the ability to adhere to plastic and the expression of specific marker proteins.
- Mesenchymal Stem Cells – A subpopulation of mesenchymal stromal cells that have the capacity to self-renew and differentiate into mesodermal lineages when cultured in vitro. The capacity to self-renew and differentiate in vivo has yet to be clearly demonstrated for mesenchymal stem cells.
References
- Dominici, M. et al. (2006) Cytotherapy 8:315.
- Keating, A. (2012) Cell Stem Cell 10:709.
Kit Components
Positive Markers:
- CD90-APC Mouse IgG2A; Clone Thy-1A1; 500 μL
- CD73-CFS Mouse IgG2B; Clone 606112; 500 μL
- CD105-PerCP Mouse IgG1; Clone 166707; 500 μL
Negative Markers:
- Negative Marker Cocktail (500 μL) that includes:
- CD45-PE Mouse IgG1; Clone 2D1
- CD34-PE Mouse IgG1; Clone QBEnd10
- CD11b-PE Mouse IgG2B; Clone 238446
- CD79A-PE Mouse IgG1; Clone 706931
- HLA-DR-PE Mouse IgG1; Clone L203
Isotype Controls:
- Mouse IgG2A-APC Isotype Control; Clone 20102; 500 μL
- Mouse IgG2B-CFS Isotype Control; Clone 133303; 500 μL
- Mouse IgG1-PerCP Isotype Control; Clone 11711; 500 μL
- Negative Isotype Cocktail (500 μL) that includes:
- Mouse IgG1-PE Isotype Control; Clone 11711
- Mouse IgG2B-PE Isotype Control; Clone 133303
- 125 mL of 1X Staining Buffer
Stability and Storage
Store at 2 °C to 8 °C in the dark. Use within 6 months of receipt.
The term 'mesenchymal stem cells' (MSCs) is most commonly used to describe multipotent self-renewing cells that can be differentiated in vitro to generate adipocytes, chondrocytes, and osteoblasts. However, because these biological properties and hierarchical relationships remain to be clearly demonstrated in vivo, the term 'multipotent mesenchymal stromal cells' is often used to distinguish cultured cells from their in vivo precursors. Originally discovered in mouse bone marrow, multipotent mesenchymal stromal cells cultured from a variety of species and tissue types, have been shown to differentiate into progeny of additional lineages including, cardiomyocytes, endothelial cells, hepatocytes, and neural cells. Again, the physiological relevance of these findings remains to be determined.